Murali Ganesan

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Mesenchymal Stem Cells

Photodynamic Therapy

Top Venues

Science advances

Alcoholism, clinical and experimental research

This page only lists publications with an associated author ORCID identifier.

Publications

Madan Kumar Arumugam, Thiyagarajan Gopal, Rakhee Rathnam Kalari Kandy, Lokesh Kumar Boopathy, Sathish Kumar Perumal, Murali Ganesan, Karuna Rasineni, Terrence M Donohue, Natalia A Osna, Kharbanda K Kusum
Mitochondrial Dysfunction-Associated Mechanisms in the Development of Chronic Liver Diseases. Biology 12 (10) (2023)
Natalia A Osna, Moses New-Aaron, Raghubendra S Dagur, Paul G Thomes, Liz Simon, Danielle Levitt, Patrick McTernan, Patricia E Molina, Hye Yeon Choi, Keigo Machida, Kenneth E Sherman, Antonio Riva, Sandra Phillips, Shilpa Chokshi, Kusum K Kharbanda, Steven Weinman, Murali Ganesan
A review of alcohol-pathogen interactions: New insights into combined disease pathomechanisms. Alcoholism, clinical and experimental research 46 (3) (2022)
Srijanee Das, Weimin Wang, Murali Ganesan, Franchesca Fonseca-Lanza, Denise A Cobb, Grace Bybee, Yimin Sun, Lili Guo, Brandon Hanson, Samuel M Cohen, Howard E Gendelman, Natalia A Osna, Benson J Edagwa, Larisa Y Poluektova
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science advances 8 (51) (2022)
Srijanee Das, Weimin Wang, Murali Ganesan, Franchesca Fonseca-Lanza, Denise A Cobb, Grace Bybee, Yimin Sun, Lili Guo, Brandon Hanson, Samuel M Cohen, Howard E Gendelman, Natalia A Osna, Benson J Edagwa, Larisa Y Poluektova
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science advances 8 (51) (2022)
Srijanee Das, Weimin Wang, Murali Ganesan, Franchesca Fonseca-Lanza, Denise A Cobb, Grace Bybee, Yimin Sun, Lili Guo, Brandon Hanson, Samuel M Cohen, Howard E Gendelman, Natalia A Osna, Benson J Edagwa, Larisa Y Poluektova
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science advances 8 (51) (2022)
Srijanee Das, Weimin Wang, Murali Ganesan, Franchesca Fonseca-Lanza, Denise A Cobb, Grace Bybee, Yimin Sun, Lili Guo, Brandon Hanson, Samuel M Cohen, Howard E Gendelman, Natalia A Osna, Benson J Edagwa, Larisa Y Poluektova
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science advances 8 (51) (2022)
Srijanee Das, Weimin Wang, Murali Ganesan, Franchesca Fonseca-Lanza, Denise A Cobb, Grace Bybee, Yimin Sun, Lili Guo, Brandon Hanson, Samuel M Cohen, Howard E Gendelman, Natalia A Osna, Benson J Edagwa, Larisa Y Poluektova
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science advances 8 (51) (2022)
Murali Ganesan, Weimin Wang, Saumi Mathews, Edward Makarov, Moses New-Aaron, Raghubendra Singh Dagur, Antje Malo, Ulrike Protzer, Kusum K Kharbanda, Carol A Casey, Larisa Y Poluektova, Natalia A Osna
Ethanol attenuates presentation of cytotoxic T-lymphocyte epitopes on hepatocytes of HBV-infected humanized mice. Alcoholism, clinical and experimental research (2021)